Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.40 |
| ▸ | PRKDC | P78527 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.34 |
| ▸ | MMP13 | P45452 | 1/20 | 0.34 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17855749 | 1.00 | ALOX5 (0.40) | ALOX5PRKDCMMP12MMP13GGPS1 | |
| SCHEMBL25814658 | 0.97 | ALOX5 (0.41) | ALOX5PRKDCMMP12MMP13GGPS1 | |
| SCHEMBL17855758 | 0.96 | ALOX5 (0.41) | ALOX5PRKDCMMP12MMP13GGPS1 | |
| SCHEMBL17855752 | 0.95 | ALOX5 (0.40) | ALOX5PRKDCMMP12MMP13GGPS1 | |
| SCHEMBL25814809 | 0.95 | ALOX5 (0.38) | ALOX5PRKDCMMP12MMP13GGPS1 | |
| SCHEMBL25814734 | 0.95 | ALOX5 (0.38) | ALOX5PRKDCMMP12MMP13GGPS1 | |
| SCHEMBL17855555 | 0.95 | ALOX5 (0.44) | ALOX5PRKDCGGPS1KDM4EMEN1 | |
| SCHEMBL17855534 | 0.95 | ALOX5 (0.44) | ALOX5PRKDCGGPS1KDM4EMEN1 | |
| SCHEMBL17855594 | 0.95 | ALOX5 (0.36) | ALOX5PRKDCMMP12MMP13GGPS1 | |
| SCHEMBL17855438 | 0.94 | ALOX5 (0.40) | ALOX5PRKDCGGPS1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160181525-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-23 | — | — | US | disclosed |
| US-20160181525-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160181525-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | ESR1, ESR2, CCNE2 | ALOX5 1603/4885PRKDC 4864/4885MMP12 4079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.